Biotech Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding LifeSci’s History of Stockholder Value Destruction and Self-Dealing December 5, 2022
Biotech CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Eiger Investors of a Lead Plaintiff Deadline of January 9, 2023 December 5, 2022
Biotech ROSEN, LEADING INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 3, 2022
Biotech ROSEN, NATIONAL TRIAL LAWYERS, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 2, 2022
Biotech Bragar Eagel & Squire, P.C. Is Investigating GrafTech, BRP, Cantaloupe, and EyePoint and Encourages Investors to Contact the Firm December 2, 2022
Biotech Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022 December 2, 2022
Biotech Aeglea BioTherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) December 2, 2022
Biotech INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm December 2, 2022
Biotech EIGR Investors Have Opportunity to Lead Eiger BioPharmaceuticals, Inc. Securities Fraud Lawsuit December 2, 2022
Search
biotech
December 5, 2022
December 5, 2022
December 3, 2022
December 2, 2022
December 2, 2022
December 2, 2022
December 2, 2022
December 2, 2022
December 2, 2022
December 2, 2022
